StockData

Universe Pharmaceuticals INC (UPC) stock

UPCNasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Sep 30, 2025Last filing: 20-F on Jan 29, 2026Score 5/30
$1.52−0.04 (-2.48%)

Close on Nov 18, 2026Market cap $857.01KP/E –Yield –

Universe Pharmaceuticals operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was -$2.92B. The highest annual figure on record is $13.59M in fiscal 2021.

Annual operating income

PeriodPeriod endValueChange
FY2025Sep 30, 2025-$2.92B–
FY2024Sep 30, 2024-$8.02B–
FY2023Sep 30, 2023-$3.97B–
FY2022Sep 30, 2022-$7.02M-151.7%
FY2021Sep 30, 2021$13.59M+32.6%
FY2020Sep 30, 2020$10.25M+5.1%
FY2019Sep 30, 2019$9.75M–

More Universe Pharmaceuticals figures

See a number that looks wrong?